Announcement on the Transfer of Equity in an Investee Company

Sunflower Pharmaceutical Group Co., Ltd.

Announcement No.: 2026-052

Announcement on the Transfer of Equity in an Investee Company

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or material omissions.

I. Transaction Overview

Sunflower Pharmaceutical Group Co., Ltd. held its 23rd meeting of the Fifth Board of Directors on July 24, 2026, and reviewed and approved the "Proposal on the Transfer of Equity in an Investee Company." The Company has decided to transfer its 10.3896% equity in Beijing PharmaStar Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "PharmaStar") (corresponding to a registered capital of RMB 3.77143 million) to Guangzhou Baiyunshan Heji Gong Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyunshan Heji Gong") for RMB 34.285768 million. Other shareholders of PharmaStar have waived their preemptive rights. Upon completion of this transfer, the Company will no longer hold any equity in PharmaStar.

This matter is within the scope of the Board of Directors' authority and does not require submission to the shareholders' meeting for deliberation.

This transaction does not constitute a related-party transaction and is not considered a major asset restructuring as defined by the "Measures for the Administration of Major Asset Restructuring of Listed Companies." The relevant details are hereby announced as follows:

II. Information on the Counterparty

1. Company Name: Guangzhou Baiyunshan Heji Gong Pharmaceutical Co., Ltd.

2. Unified Social Credit Code: 91440111MACAJ4Y413

3. Enterprise Type: Limited Liability Company (Wholly Owned by a Legal Person)

4. Registered Address: No. 52, Damashi Road, Xinshi Street, Baiyun District, Guangzhou City

5. Legal Representative: Meng Jun

6. Date of Establishment: 2023-02-23

7. Registered Capital: RMB 66 million

Sunflower Pharmaceutical

1. Business Scope: Production of medical protective equipment (Class I medical devices); sales of Class I medical devices; sales of Class II medical devices; wholesale of cosmetics; sales of food (pre-packaged food only); online sales of food (pre-packaged food only); manufacturing of daily chemical products; property management; housing leasing; leasing of non-residential real estate; sales of sanitary products and disposable medical devices; retail of cosmetics; wholesale of kitchen and bathroom appliances and daily sundries; human resources services (excluding occupational intermediary services, labor dispatch services); sales of Class III medical devices; import and export of goods; production of pharmaceuticals; wholesale of pharmaceuticals; retail of pharmaceuticals; production of medical protective equipment (Class II medical devices); production of sanitary products and disposable medical devices; production of cosmetics; production of health foods; production of beverages; production of alcoholic beverages; wine sales; food sales.

2. Current Equity Structure: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. holds 100%.

Upon inquiry, Baiyunshan Heji Gong is not a dishonest judgment debtor. There is no relationship with the Company, shareholders holding more than 5% of the Company's shares, directors, or senior management personnel, nor are there any other circumstances that could lead to the Company's interests being tilted towards it.

III. Basic Information of the Transaction Target